Notch receptors in GtoPdb v.2021.2

Abstract


Aberrant Notch signalling is implicated in a number of human cancers [18, 26, 13, 21], and there is intense pharmaceutical activity being directed towards achieving clinically effective Notch pathway inhibition [7, 16].

DOI: https://doi.org/10.2218/gtopdb/F914/2021.2
Published
25-Jun-2021
How to Cite
Arumugam, T. V. and Sobey, C. (2021) “Notch receptors in GtoPdb v.2021.2”, IUPHAR/BPS Guide to Pharmacology CITE, 2021(2). doi: 10.2218/gtopdb/F914/2021.2.
Issue
Vol 2021 No 2 (2021)
Section
Summaries
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.